Physician profile
Amit Patel
NPI 1861750028
$7,404.90
in general payments reported to CMS, 2019-2025
28 companies · $1,047 in 2025
The $1,047 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $255 · 2020: $416 · 2021: $873 · 2022: $1,360 · 2023: $1,388 · 2024: $2,066 · 2025: $1,047.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,254 · Travel and Lodging: $224 · Education: $22.41.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,254.40 |
| Travel and Lodging | $223.74 |
| Education | $22.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $2,477.40 | 2020-2025 | Relistor, Trulance |
| Medtronic, INC. | $1,251.78 | 2021-2025 | Intellis Adaptivestim |
| Nalu Medical, INC. | $594.35 | 2024 | Nalu Neurostimulation System |
| Curonix LLC | $473.20 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic USA, INC. | $365.17 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $299.86 | 2022-2025 | Xtampza |
| Boston Scientific Corporation | $265.85 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Spr Therapeutics, INC | $252.60 | 2021-2022 | |
| Uswm, LLC | $248.00 | 2021-2022 | |
| Painteq LLC | $226.33 | 2021-2022 | |
| Radius Health, INC. | $178.35 | 2019-2022 | |
| Stryker Corporation | $150.00 | 2024 | Mild Device Kit |
| Nevro Corp. | $115.25 | 2024 | Senza |
| Redhill Biopharma INC. | $107.45 | 2020-2022 | |
| Daiichi Sankyo INC. | $57.05 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $50.86 | 2023 | Horizant |
| Gilead Sciences, INC. | $48.29 | 2025 | Trodelvy |
| Spinal Simplicity, LLC | $43.74 | 2025 | Ha Minuteman G3-R |
| Abbott Laboratories | $42.21 | 2020-2022 | |
| Djo, LLC | $25.92 | 2025 | Cmf |
| Vertex Pharmaceuticals Incorporated | $23.31 | 2025 | |
| Scilex Pharmaceuticals INC. | $22.94 | 2022 | |
| Resmed Corp | $19.12 | 2023 | |
| Masimo Corporation | $18.74 | 2023 | Patient Safetynet System |
| Biodelivery Sciences International, INC. | $16.01 | 2021 | |
| Protega Pharmaceutials INC | $13.54 | 2025 | Roxybond |
| Arbor Pharmaceuticals, INC. | $13.25 | 2022 | |
| Vertos Medical, INC. | $4.33 | 2024 | Mild Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.